Relationship between initial margin status for invasive breast cancer and residual carcinoma after re-excision

American Surgeon

Volumn 73, Issue 4, 2007, Pages 337-343

  Kotwall, Cyrus ^a,b,c   Ranson, Mark ^b,c   Stiles, Anquonette ^c   Hamann, Mary Sue ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

^c New Hanover Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER INVASION; CANCER SURGERY; HEALTH CARE FACILITY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PATHOLOGY; REINFORCEMENT; REOPERATION; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; TUMOR VOLUME; BREAST TUMOR; FEMALE; LYMPH NODE METASTASIS; PAGET NIPPLE DISEASE; SEGMENTAL MASTECTOMY;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; NEOPLASM, RESIDUAL; REOPERATION; RETROSPECTIVE STUDIES;

EID: 34248598819     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347:1233-41.
2. Singletary SE. Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 2002;184:383-93.
3. Jardines L, Fowble B, Schultz D, et al. Factors associated with a positive reexcision after excisional biopsy for invasive breast cancer. Surgery 1995;118:803-9.
4. Gwin J, Eisenberg B, Hoffman J, et al. Incidence of gross and microscopic carcinoma in specimens from patients with breast cancer after re-excision lumpectomy. Ann Surg 1993;218:729-34.
5. Kearney TJ, Morrow M. Effect of reexcision on the success of breast-conserving surgery. Ann Surg Oncol 1995;2:303-7.
6. Papa M, Zippel D, Koller M, et al. Positive margins of breast biopsy: Is reexcision always necessary? J Surg Oncol 1999;70:167-71.
7. Newman L, Washington T. New trends in breast conservation therapy. Surg Clin N Am 2003;83:841-83.
8. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: Does each focus matter. J Clin Oncol 2005;23:7497-502.
9. Dillon MF, Hill ADK, Fleming FJ, et al. Identifying patients at risk of compromised margins following breast conservation for lobular carcinoma. Am J Surg 2006;191:201-5.
10. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999;353:1993-2000.
11. Fisher B, Land S, Mamounas E, et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400.
12. Gage I, Schnitt S, Nixon AJ, et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 1996;78:1921-28.
13. Kotwall C, Covington D, Churchill P, et al. Breast conservation surgery for breast cancer at a regional medical center. Am J Surg 1998;176:510-14.
14. Taghian A, Mohiuddin M, Jagsi R, et al. Current perceptions regarding surgical margin status after breast-conserving therapy: Results of a survey. Ann Surg 2005;241:629-39.
15. Klimberg VS, Westbrook KC, Korourian S. Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 1998;5:220-6.
16. Menes TS, Tartter PI, Bleiweiss I, et al. The consequence of multiple re-escisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol 2005;12:881-5.